Beom Suk Lee

806 total citations
21 papers, 651 citations indexed

About

Beom Suk Lee is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Beom Suk Lee has authored 21 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Biomaterials and 6 papers in Biomedical Engineering. Recurrent topics in Beom Suk Lee's work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Autophagy in Disease and Therapy (3 papers). Beom Suk Lee is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Autophagy in Disease and Therapy (3 papers). Beom Suk Lee collaborates with scholars based in South Korea, China and India. Beom Suk Lee's co-authors include Ick Chan Kwon, Kwangmeyung Kim, Samil Jung, Sang Yoon Kim, Soon Hong Yuk, Myeong‐Sok Lee, Sang-Yoon Kim, Keun Sang Oh, ChangJu Chun and Kuiwon Choi and has published in prestigious journals such as Biomaterials, JNCI Journal of the National Cancer Institute and Food Chemistry.

In The Last Decade

Beom Suk Lee

21 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beom Suk Lee South Korea 14 273 272 246 76 66 21 651
Kuan Jiang China 17 648 2.4× 377 1.4× 382 1.6× 70 0.9× 147 2.2× 19 1.0k
Larissa Yokota Rizzo Germany 13 286 1.0× 335 1.2× 382 1.6× 166 2.2× 32 0.5× 15 953
Xiqin Yang China 15 283 1.0× 238 0.9× 335 1.4× 71 0.9× 24 0.4× 16 644
Minsu Lee South Korea 13 381 1.4× 168 0.6× 134 0.5× 58 0.8× 31 0.5× 35 779
Yingwen Hu China 11 206 0.8× 295 1.1× 230 0.9× 64 0.8× 48 0.7× 15 568
Ahmed Shaker Eltahan China 8 192 0.7× 212 0.8× 329 1.3× 194 2.6× 31 0.5× 11 641
Zhihao Han China 17 470 1.7× 172 0.6× 393 1.6× 202 2.7× 34 0.5× 54 954
Jian-Bin Qiao China 14 299 1.1× 267 1.0× 268 1.1× 122 1.6× 38 0.6× 20 811

Countries citing papers authored by Beom Suk Lee

Since Specialization
Citations

This map shows the geographic impact of Beom Suk Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beom Suk Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beom Suk Lee more than expected).

Fields of papers citing papers by Beom Suk Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beom Suk Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beom Suk Lee. The network helps show where Beom Suk Lee may publish in the future.

Co-authorship network of co-authors of Beom Suk Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Beom Suk Lee. A scholar is included among the top collaborators of Beom Suk Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beom Suk Lee. Beom Suk Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Samil, et al.. (2022). SERTAD1 Sensitizes Breast Cancer Cells to Doxorubicin and Promotes Lysosomal Protein Biosynthesis. Biomedicines. 10(5). 1148–1148. 4 indexed citations
2.
Li, Shangyong, Ningning He, Qi Han, et al.. (2020). Production of a thermo-tolerant κ-carrageenase via a food-grade host and anti-oxidant activity of its enzymatic hydrolysate. Food Chemistry. 339. 128027–128027. 20 indexed citations
3.
Mongre, Raj Kumar, et al.. (2020). Exploring the Role of TRIP-Brs in Human Breast Cancer: An Investigation of Expression, Clinicopathological Significance, and Prognosis. Molecular Therapy — Oncolytics. 19. 105–126. 8 indexed citations
4.
Li, Shangyong, Linna Wang, Samil Jung, et al.. (2020). Biochemical Characterization of a New Oligoalginate Lyase and Its Biotechnological Application in Laminaria japonica Degradation. Frontiers in Microbiology. 11. 316–316. 16 indexed citations
5.
Jung, Samil, et al.. (2020). Inhibitory Role of TRIP-Br1/XIAP in Necroptosis under Nutrient/Serum Starvation.. PubMed. 43(3). 236–250. 7 indexed citations
6.
Mongre, Raj Kumar, Chandra Bhushan Mishra, Amresh Prakash, et al.. (2019). Novel Carbazole-Piperazine Hybrid Small Molecule Induces Apoptosis by Targeting BCL-2 and Inhibits Tumor Progression in Lung Adenocarcinoma In Vitro and Xenograft Mice Model. Cancers. 11(9). 1245–1245. 36 indexed citations
7.
Li, Shangyong, Yanan Wang, Xiao Li, et al.. (2019). Enhancing the Thermo-Stability and Anti-Biofilm Activity of Alginate Lyase by Immobilization on Low Molecular Weight Chitosan Nanoparticles. International Journal of Molecular Sciences. 20(18). 4565–4565. 40 indexed citations
8.
Jung, Samil, et al.. (2018). Inhibitory role of AMP‑activated protein kinase in necroptosis of HCT116 colon cancer cells with p53 null mutation under nutrient starvation. International Journal of Oncology. 54(2). 702–712. 8 indexed citations
9.
Jung, Samil, Hyung‐In Moon, Beom Suk Lee, et al.. (2018). Anti-cancerous effect of cis-khellactone from Angelica amurensis through the induction of three programmed cell deaths. Oncotarget. 9(24). 16744–16757. 8 indexed citations
10.
Jo, Sung Duk, Jae‐Won Lee, Min Kyung Joo, et al.. (2018). PEG–PLA-Coated and Uncoated Radio-Luminescent CaWO4 Micro- and Nanoparticles for Concomitant Radiation and UV-A/Radio-Enhancement Cancer Treatments. ACS Biomaterials Science & Engineering. 4(4). 1445–1462. 19 indexed citations
11.
Jo, Sung Duk, Ji Young Yhee, Beom Suk Lee, et al.. (2017). Synergistic anti-tumor effects of bevacizumab and tumor targeted polymerized VEGF siRNA nanoparticles. Biochemical and Biophysical Research Communications. 489(1). 35–41. 28 indexed citations
12.
Chung, Seung Woo, Seho Kweon, Beom Suk Lee, et al.. (2017). Radiotherapy‐assisted tumor selective metronomic oral chemotherapy. International Journal of Cancer. 141(9). 1912–1920. 8 indexed citations
13.
Oh, Keun Sang, Jae‐Young Lee, Beom Suk Lee, et al.. (2016). Doxorubicin/gold-loaded core/shell nanoparticles for combination therapy to treat cancer through the enhanced tumor targeting. Journal of Controlled Release. 228. 141–149. 45 indexed citations
14.
Chung, Seung Woo, Beom Suk Lee, Jeong Uk Choi, et al.. (2015). Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis. Journal of Medicinal Chemistry. 58(16). 6435–6447. 24 indexed citations
15.
Lee, Beom Suk, Yong Woo Cho, Do Hee Lee, et al.. (2014). Induced Phenotype Targeted Therapy: Radiation-Induced Apoptosis-Targeted Chemotherapy. JNCI Journal of the National Cancer Institute. 107(2). 59 indexed citations
16.
Chung, Seung Woo, Myungjin Lee, Sang Mun Bae, et al.. (2012). Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge. Biomaterials. 33(35). 9070–9079. 20 indexed citations
17.
Choi, Ki Young, Eun Jung Jeon, Hong Yeol Yoon, et al.. (2012). Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Biomaterials. 33(26). 6186–6193. 124 indexed citations
18.
Lee, Beom Suk, et al.. (2011). Long-term theranostic hydrogel system for solid tumors. Biomaterials. 33(7). 2251–2259. 67 indexed citations
19.
Yuk, Soon Hong, Keun Sang Oh, Sun Hang Cho, et al.. (2011). Glycol Chitosan/Heparin Immobilized Iron Oxide Nanoparticles with a Tumor-Targeting Characteristic for Magnetic Resonance Imaging. Biomacromolecules. 12(6). 2335–2343. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026